Business Segment Information

6 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Business Segment Information

15. Business Segment Information

The Company has three reportable segments, BSI Life Science, BSI Nano and BEST, as discussed in Note 1 to the unaudited condensed consolidated financial statements.

Revenue and operating income by reportable segment are presented below (in millions):

	Three Months Ended June 30,						Six Months Ended June 30,
	2022			2021			2022			2021
Revenue:
BSI Life Science	$	350.1		$	341.8		$	711.1		$	693.6
BSI Nano		182.2			175.3			360.7			329.7
BEST		59.2			56.6			118.9			109.0
Eliminations (a)		(3.1	)		(2.9	)		(7.3	)		(6.8	)
Total revenue	$	588.4		$	570.8		$	1,183.4		$	1,125.5
Operating income (loss):
BSI Life Science	$	70.2		$	73.6		$	156.1		$	162.5
BSI Nano		14.6			21.0			36.9			33.3
BEST		6.6			6.8			13.2			10.9
Corporate, eliminations and other (b)		(17.5	)		(15.8	)		(35.8	)		(32.0	)
Total operating income	$	73.9		$	85.6		$	170.4		$	174.7

(a)Represents product and service revenue between reportable segments.

(b)Represents corporate costs and eliminations not allocated to the reportable segments.

Total assets by reportable segment are as follows (in millions):

	June 30, 2022			December 31, 2021
Assets:
BSI Life Science, BSI Nano & Corporate	$	3,298.3		$	3,560.5
BEST		93.1			97.9
Eliminations and other (a)		(6.6	)		(8.4	)
Total assets	$	3,384.8		$	3,650.0

(a)Assets not allocated to the reportable segments and eliminations of intercompany transactions.

The Company is unable, without unreasonable effort or expense, to disclose the amount of total assets held by its BSI Life Science and BSI Nano segments as well as the Corporate function and further, the Company’s chief operating decision maker does not receive any asset information by operating segment.